Skip to content

About US
About LB-102
Pipeline
Publications
Investors
Careers
Contact Us

2025 Annual Congress of the Schizophrenia International Research Society (SIRS)

March 29, 2025

– April 2, 2025

Chicago, Illinois

LB-102 for Acute Schizophrenia in Adults: Efficacy and Safety from a Large Phase 2 Clinical Trial

view ALL Events

About US
About LB-102
Pipeline
Publications
Investors
Careers
Contact Us

About US
About LB-102
Pipeline
Publications
Investors
Careers
Contact Us

All Rights Reserved.

About Us
Management
Board of Directors
Scientific Advisory Board
Careers
Contact Us

About LB-102
Pipeline
About Schizophrenia
Publications

Investors Overview
News
Events
Corporate Governance
SEC Filings
Stock Information
Investor FAQs

© 2025 LB Pharmaceuticals, a clinical-stage biopharmaceutical company developing novel therapies for the treatment of neuropsychiatric diseases, including schizophrenia.

Scroll to Top